Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Revenues | $ 25,084,631 | $ 22,469,543 | $ 48,791,421 | $ 40,202,999 |
| Expenses | ||||
| Cost of services (content, hosting, and other) | 26,542,307 | 35,692,133 | 56,578,481 | 67,520,487 |
| General and administrative | 11,666,331 | 10,415,016 | 28,300,054 | 19,737,395 |
| Research and development | 4,825,884 | 5,319,230 | 9,614,995 | 9,847,022 |
| Sales and marketing | 7,891,526 | 6,274,749 | 11,530,452 | 9,571,491 |
| Acquisition-related transaction costs | 2,388,105 | 2,388,105 | ||
| Amortization and depreciation | 3,602,160 | 3,564,219 | 6,894,869 | 5,990,361 |
| Changes in fair value of digital assets | (5,192,441) | (3,493,025) | ||
| Changes in fair value of contingent consideration | 17,768 | 1,354,357 | ||
| Total expenses | 51,723,872 | 61,283,115 | 111,813,931 | 114,021,113 |
| Loss from operations | (26,639,241) | (38,813,572) | (63,022,510) | (73,818,114) |
| Interest income | 2,898,945 | 2,174,166 | 5,083,231 | 4,696,118 |
| Other expense | (22,773) | (3,869) | (47,377) | (73,577) |
| Changes in fair value of derivative | 9,700,000 | |||
| Changes in fair value of warrant liability | (6,461,861) | 10,014,200 | 15,442,843 | (723,695) |
| Loss before income taxes | (30,224,930) | (26,629,075) | (32,843,813) | (69,919,268) |
| Income tax expense | (151,625) | (31,310) | (151,472) | |
| Net loss | $ (30,224,930) | $ (26,780,700) | $ (32,875,123) | $ (70,070,740) |
| Loss per share – basic (in Dollars per share) | $ (0.12) | $ (0.13) | $ (0.13) | $ (0.35) |
| Loss per share – diluted (in Dollars per share) | $ (0.12) | $ (0.13) | $ (0.13) | $ (0.35) |
| Weighted-average number of common shares used in computing net loss per share - basic (in Shares) | 260,327,707 | 204,091,819 | 248,754,135 | 202,998,041 |
| Weighted-average number of common shares used in computing net loss per share - diluted (in Shares) | 260,327,707 | 204,091,819 | 248,754,135 | 202,998,041 |
| Total share-based compensation expense | $ 5,379,294 | $ 6,557,381 | $ 14,064,097 | $ 11,320,275 |
| Cost of services (content, hosting, and other) | ||||
| Expenses | ||||
| Total share-based compensation expense | 1,036,433 | 2,538,203 | 2,563,013 | 2,927,113 |
| General and administrative | ||||
| Expenses | ||||
| Total share-based compensation expense | 2,950,885 | 3,061,516 | 9,235,196 | 7,037,387 |
| Research and development | ||||
| Expenses | ||||
| Total share-based compensation expense | 915,006 | 666,468 | 1,541,441 | 937,340 |
| Sales and marketing | ||||
| Expenses | ||||
| Total share-based compensation expense | $ 476,970 | $ 291,194 | $ 724,447 | $ 418,435 |
| X | ||||||||||
- Definition Represent the amount of change in fair value of digital assets. No definition available.
|
| X | ||||||||||
- Definition The amount of changes in fair value of contingent consideration. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|